Stoke Therapeutics Inc (STOK)

Stock-Based Compensation

$10.80M

Quarterly · Period ending: · USD

STOK logo

STOK Stock-Based Compensation

Latest reported$10.80M
STOK Quarterly Stock-Based Comp ($4.00K → $10.80M)
High-resolution chart · PNG

STOK stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Stoke Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
10,802,000
8,753,000
9,848,000
0
7,598,000
6,753,000
7,139,000
7,594,000
7,427,000
5,510,000
6,058,000
6,652,000
6,760,000
5,887,000
5,790,000
5,926,000
6,163,000
4,975,000
4,686,000
4,614,000
4,452,000
2,698,000
1,580,000
1,785,000
1,649,000
754,000
712,000
731,000
298,000
181,000
119,000
40,000
77,000
4,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.